Kao Corp. Aktie
32,79 €
Deine Einschätzung
Kao Corp. Aktie
Was spricht für und gegen Kao Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Kao Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Kao Corp. | -1,65 % | 5,61 % | 2,18 % | -19,04 % | -2,71 % | -0,48 % | -36,13 % |
| Unicharm Corp. | -5,38 % | 7,88 % | 5,26 % | - | 7,00 % | - | - |
| Pola Orbis Holdings Inc. | -0,75 % | 2,29 % | -0,74 % | -16,25 % | -3,60 % | -50,00 % | -69,55 % |
| Kose Corp | 0,00 % | -1,41 % | -10,26 % | -20,45 % | 0,00 % | -70,53 % | -78,95 % |
Kommentare
News
Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders
On May 11, 2026, John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 298,000 shares of common stock for a total transaction value of
Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes
Alignment Healthcare (NASDAQ:ALHC) executives said the company remains confident in its second-quarter outlook, citing stable medical cost
Alignment Healthcare CEO Sells $2.1 Million in Shares. Here's What Investors Should Know
John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 118,000 shares for a transaction value of about $2.06 million, according to a SEC Form 4





